Key facts
- This page summarizes Aaron Ondrey's Form 4 filing for ROCKET PHARMACEUTICALS, INC. (RCKT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jul 2025, 16:05.
Aaron Ondrey - 03 Jul 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RCKT
- Reported as of
- 03 Jul 2025
- Net transaction value
- -$4,257
- SEC form
- 4
- Accepted by SEC
- 08 Jul 2025, 16:05:11 UTC
- Prior SEC filing
- 08 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Martin Wilson, as attorney-in-fact for Aaron Ondrey
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Aaron Ondrey filed Form 4 for ROCKET PHARMACEUTICALS, INC. (RCKT) on 08 Jul 2025.
Change
- Previous filing in this sequence was filed on 08 Apr 2025.
- Current net transaction value: -$4,257.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001991078
Primary reporting owner
Ondrey Aaron
- Relationship
- Chief Financial Officer
- Address
- C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY
- Signature
- /s/ Martin Wilson, as attorney-in-fact for Aaron Ondrey
- Signature date
- 08 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RCKT
transaction
Common Stock
Sale
- Transaction value
- $4,257
- Shares
- -1,477
- Change %
- -1.1%
- Price
- $2.88
- Shares after
- 128,173
- Date
- 03 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
Footnote F2
The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.